**Patient Discharge Summary**

**Patient Information:**

* Patient Name: Jane Doe
* Date of Birth: March 12, 1985
* Admission Date: March 10, 2023
* Discharge Date: March 20, 2023
* Hospital Number: 123456

**Chief Complaint and History of Present Illness:**

Jane Doe, a 38-year-old non-smoking female, was admitted to the Endocrinology unit on March 10, 2023, with a chief complaint of fatigue, weight gain, and hair loss over the past six months. She reported a history of depression and hypothyroidism in her family. Her symptoms worsened despite taking over-the-counter thyroid supplements.

**Admission Findings and Initial Work-up:**

Upon admission, Jane's physical examination revealed a normal vital signs, except for a slightly elevated blood pressure (140/90 mmHg). Her thyroid gland was normal in size and consistency. Laboratory results showed an elevated serum thyroid-stimulating hormone (TSH) level of 30.5 μIU/mL (normal range: 0.4-4.0 μIU/mL) and a low free thyroxine (T4) level of 0.5 ng/dL (normal range: 0.9-1.7 ng/dL). Her complete blood count (CBC) revealed a normocytic-normochromic anemia with a hemoglobin level of 12.2 g/dL. Her lipid profile showed elevated total cholesterol and low-density lipoprotein (LDL) cholesterol levels.

**Diagnosis:**

Based on the laboratory results and clinical presentation, Jane was diagnosed with primary hypothyroidism.

**Treatment and Course:**

Jane was started on levothyroxine therapy at a dose of 100 mcg orally once a day. Her medication regimen was as follows:

* Levothyroxine 100 mcg orally once a day
* Folic acid 1 mg orally once a day
* Multivitamin orally once a day

Her thyroid function tests were monitored closely, and her TSH level decreased to 2.5 μIU/mL by the 14th day of admission. Her free T4 level increased to 1.2 ng/dL, and her anemia improved with a hemoglobin level of 13.5 g/dL.

**Complications and Interventions:**

Jane developed mild hypoxemia during her hospital stay, which was managed with supplemental oxygen therapy. She did not require mechanical ventilatory assistance.

**Discharge Instructions:**

Jane was discharged on March 20, 2023, with the following instructions:

* Continue taking levothyroxine 100 mcg orally once a day
* Monitor her thyroid function tests every 6-8 weeks
* Report any changes in symptoms or medication side effects to her primary care physician
* Follow up with her primary care physician in 2 weeks for a follow-up appointment

**Patient Education:**

Jane was educated on the importance of taking her medication as directed, the need for regular follow-up appointments, and the potential side effects of levothyroxine therapy. She was also advised to report any changes in her symptoms or medication side effects to her primary care physician.

**Follow-up:**

Jane is scheduled to follow up with her primary care physician in 2 weeks for a follow-up appointment. She will be monitored closely for any changes in her thyroid function tests and for any signs of medication side effects.

**Conclusion:**

Jane Doe was successfully treated for primary hypothyroidism with levothyroxine therapy. Her symptoms improved significantly, and her thyroid function tests normalized. She was discharged with a plan for regular follow-up appointments and education on the importance of taking her medication as directed.